Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting, 39712-39713 [2012-16350]
Download as PDF
<![CDATA[
39712
Federal Register / Vol. 77, No. 129 / Thursday, July 5, 2012 / Notices
or other forms of information
technology.
Proposed Project: Health Center
Controlled Networks (OMB No. 0915–
xxxx)—[New]
One goal of the Health Resources and
Services Administration (HRSA) is to
ensure that all Health Center program
grantees effectively implement health
information technology (HIT) systems
that enable all providers to become
meaningful users of HIT, including
Electronic Health Records (EHRs), and
use those systems to increase access to
care, improve quality of care, and
reduce the costs of care delivered. The
Health Center Controlled Network
(HCCN) program serves as a major
component of HRSA’s HIT initiative to
support these goals. The HCCN model
focuses on the integration of certain
functions and the sharing of skills,
resources, and data to improve health
center operations and care provision,
and generating efficiencies and
economies of scale. Through this grant,
HCCNs will provide support for the
adoption, implementation, and
meaningful use of Health Information
Technology (HIT) to improve the quality
of care provided by existing Health
Center Program grantees (i.e., Section
330 funded health centers) by engaging
in the following program components:
• Adoption and Implementation:
Assist participating health centers with
effectively adopting and implementing
certified EHR technology.
• Meaningful Use: Support
participating health centers in meeting
Meaningful Use requirements and
accessing incentive payments under the
Medicare and Medicaid Electronic
Health Records Incentive Programs.
• Quality Improvement: Advance
participating health centers’ QI
initiatives to improve clinical and
operational quality, including Patient
Centered Medical Home (PCMH)
recognition.
HRSA plans to collect and evaluate
network outcome measures. HRSA
plans to require that HCCNs report such
measures to HRSA in annual work plan
updates as part of their annual, noncompeting continuation progress reports
through an electronic reporting system.
The work plan updates will include
information on grantees’ plans and
progress on the following:
Number of
respondents
Instrument
Responses
per
respondent
• Adoption and Implementation of
HIT (including EHR);
• Attainment of Meaningful Use
Requirements; and
• Quality improvement measures
(e.g., Healthy People 2020 clinical
quality measures, PCMH recognition
status, etc.).
The annual, non-competing
continuation progress reports will
describe each grantee’s progress in
achieving key activity goals such as
quality improvement, data access and
exchange, efficiency and effectiveness of
network services, and the ability to track
and monitor patient outcomes, as well
as emerging needs, challenges and
barriers encountered customer
satisfaction, and plans to meet goals for
the next year. Grantees will submit their
work plan updates and annual, noncompeting continuation progress report
each fiscal year of the grant; the
submission and subsequent HRSA
approval of each report triggers the
budget period renewal and release of
each subsequent year of funding. The
estimated total number of burden hours
is 750.
The annual estimate of burden is as
follows:
Total
responses
Total
burden
hours
Hours per
response
Work Plan Update ................................................................
Annual Progress Report/Interim Evaluation Progress Report ...................................................................................
30
1
30
5
150
30
1
30
20
600
Total ..............................................................................
60
........................
........................
........................
750
Email comments to
paperwork@hrsa.gov or mail the HRSA
Reports Clearance Officer, Room 10–29,
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments
should be received within 60 days of
this notice.
Dated: June 28, 2012.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2012–16332 Filed 7–3–12; 8:45 am]
TKELLEY on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4165–15–P
VerDate Mar<15>2010
16:48 Jul 03, 2012
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposal and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposal, the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; National Children’s
Study Vanguard 2.0.
Date: July 23, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute Of Child
Health and Human Development, 6100
Executive Boulevard, Rockville, MD 20892–
9304, (301) 435–6680,
skandasa@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
E:\FR\FM\05JYN1.SGM
05JYN1
Federal Register / Vol. 77, No. 129 / Thursday, July 5, 2012 / Notices
Dated: June 27, 2012.
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–16350 Filed 7–3–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
TKELLEY on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; Review of RFA AA–12–010.
Date: July 18, 2012.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH, 5635 Fishers Lane, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch
EPRB, NIAAA, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@mail.
nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member conflict
SEP—Neurosciences.
Date: July 25, 2012.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
MSC9304, 5635 Fishers Lane, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch
EPRB, NIAAA, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@mail.
nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
Reviews—Biosciences.
Date: July 30, 2012.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
16:48 Jul 03, 2012
Jkt 226001
Place: National Institutes of Health, 5635
Fishers Lane, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch
EPRB, NIAAA, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@mail.
nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
applications Clinical and Treatment Related
Applications.
Date: August 2, 2012.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch
EPRB, NIAAA, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@mail.
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: June 26, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–16340 Filed 7–3–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Feasibility
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
39713
Studies for Collaborative Interaction for
Minority Institution/Cancer Center
Partnership.
Date: July 10–11, 2012.
Time: 7 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Room 8101, Bethesda,
MD 20892–8329, 301–496–7987,
lovingeg@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R13
Application Review.
Date: July 17, 2012.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Bratin K. Saha, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8041, Bethesda, MD 20892, 301–402–
0371, sahab@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R01 and
R03 Grant Applications.
Date: July 17, 2012.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Cancer Institute, 6116 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Olivia Bartlett, Ph.D.,
Chief, Research Programs Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 6116 Executive Blvd.,
Room 8121, Bethesda, MD 20892–7405, 301–
594–2501, op2t@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Institutional Training and Education Grants.
Date: July 24, 2012.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Cancer Institute, 6116 Executive
Boulevard, Room 707, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Timothy C. Meeker, MD,
Ph.D., Scientific Review Officer, Resources
E:\FR\FM\05JYN1.SGM
05JYN1
]]>Agencies
[Federal Register Volume 77, Number 129 (Thursday, July 5, 2012)]
[Notices]
[Pages 39712-39713]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-16350]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposal and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposal, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; National Children's Study
Vanguard 2.0.
Date: July 23, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Sathasiva B. Kandasamy, Ph.D., Scientific Review
Officer, Division of Scientific Review, National Institute Of Child
Health and Human Development, 6100 Executive Boulevard, Rockville,
MD 20892-9304, (301) 435-6680, skandasa@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
[[Page 39713]]
Dated: June 27, 2012.
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-16350 Filed 7-3-12; 8:45 am]
BILLING CODE 4140-01-P
